CD8A and sarcoma: To further validate the NLGP activated CD8+ T cell mediated killing of MDSCs, we in vitro cultured purified MDSCs from solid sarcoma in the presence and absence of supernatants of purified CD8+ T cells which were treated with NLGP (Fig 4F).